Dana Alexander

Biography

  Dana Alexander joined Anika Therapeutics, Inc. as its Chief Operations Officer on April 4, 2016. Prior to joining Anika, Dana spent the previous 14 years in various leadership roles at Genzyme Corporation.   Most recently, Mr. Alexander served as Senior Director of Biologics Manufacturing Operations, where he headed manufacturing at Genzyme’s flagship biologics plant including overseeing production planning and execution, bringing new manufacturing capacity on-line, and implementing new production and quality systems. During his tenure at Genzyme, Mr. Alexander provided operational oversight for the construction, start-up, and approval of a new cGMP cell culture facility, managed Chemistry, Manufacturing, and Control (CMC) activities for a variety of late stage and commercial products, and led operation product teams across complex supply chains to deliver global clinical and commercial supply requirements. Dana holds a Master’s in Business Administration from Boston University, and a Bachelor of Science in Chemical Engineering from Northeastern University.

Research Interest